Your browser doesn't support javascript.
loading
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.
Campbell, Nathaniel R; Rao, Anjali; Hunter, Miranda V; Sznurkowska, Magdalena K; Briker, Luzia; Zhang, Maomao; Baron, Maayan; Heilmann, Silja; Deforet, Maxime; Kenny, Colin; Ferretti, Lorenza P; Huang, Ting-Hsiang; Perlee, Sarah; Garg, Manik; Nsengimana, Jérémie; Saini, Massimo; Montal, Emily; Tagore, Mohita; Newton-Bishop, Julia; Middleton, Mark R; Corrie, Pippa; Adams, David J; Rabbie, Roy; Aceto, Nicola; Levesque, Mitchell P; Cornell, Robert A; Yanai, Itai; Xavier, Joao B; White, Richard M.
Afiliação
  • Campbell NR; Weill Cornell/Rockefeller Memorial Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY 10065, USA; Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, U
  • Rao A; Institute for Computational Medicine, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Hunter MV; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Sznurkowska MK; Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.
  • Briker L; Department of Dermatology, University of Zürich Hospital, University of Zürich, Zurich, Switzerland.
  • Zhang M; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Baron M; Institute for Computational Medicine, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Heilmann S; Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Deforet M; Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kenny C; Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242, USA.
  • Ferretti LP; Department of Dermatology, University of Zürich Hospital, University of Zürich, Zurich, Switzerland; Department of Molecular Mechanisms of Disease, University of Zürich, Zurich, Switzerland.
  • Huang TH; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Perlee S; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Garg M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridgeshire, UK.
  • Nsengimana J; Leeds Institute of Medical Research at St. James's, University of Leeds School of Medicine, Leeds, UK.
  • Saini M; Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.
  • Montal E; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Tagore M; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Newton-Bishop J; Leeds Institute of Medical Research at St. James's, University of Leeds School of Medicine, Leeds, UK.
  • Middleton MR; Oxford NIHR Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
  • Corrie P; Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Adams DJ; Experimental Cancer Genetics, the Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK.
  • Rabbie R; Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Experimental Cancer Genetics, the Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK.
  • Aceto N; Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.
  • Levesque MP; Department of Dermatology, University of Zürich Hospital, University of Zürich, Zurich, Switzerland.
  • Cornell RA; Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242, USA.
  • Yanai I; Institute for Computational Medicine, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Xavier JB; Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: xavierj@mskcc.org.
  • White RM; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: whiter@mskcc.org.
Dev Cell ; 56(20): 2808-2825.e10, 2021 10 25.
Article em En | MEDLINE | ID: mdl-34529939
ABSTRACT
Melanomas can have multiple coexisting cell states, including proliferative (PRO) versus invasive (INV) subpopulations that represent a "go or grow" trade-off; however, how these populations interact is poorly understood. Using a combination of zebrafish modeling and analysis of patient samples, we show that INV and PRO cells form spatially structured heterotypic clusters and cooperate in the seeding of metastasis, maintaining cell state heterogeneity. INV cells adhere tightly to each other and form clusters with a rim of PRO cells. Intravital imaging demonstrated cooperation in which INV cells facilitate dissemination of less metastatic PRO cells. We identified the TFAP2 neural crest transcription factor as a master regulator of clustering and PRO/INV states. Isolation of clusters from patients with metastatic melanoma revealed a subset with heterotypic PRO-INV clusters. Our data suggest a framework for the co-existence of these two divergent cell populations, in which heterotypic clusters promote metastasis via cell-cell cooperation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise por Conglomerados / Melanoma / Células Neoplásicas Circulantes / Metástase Neoplásica Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise por Conglomerados / Melanoma / Células Neoplásicas Circulantes / Metástase Neoplásica Idioma: En Ano de publicação: 2021 Tipo de documento: Article